METAVIA INC. Shareholders' Equity
METAVIA INC. (MTVA) had Shareholders' Equity of $6.82 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $6.82M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $9.07M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $5.33M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $6.33M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $6.82M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $9.07M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $5.33M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $6.33M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $9.62M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $4.38M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $7.93M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $12.95M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $18.94M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $10.08M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $16.68M 10-K · filed 2026-03-26 | |
| 2023-09-30 | $21.55M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $25.20M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $20.51M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $21.75M 10-K · filed 2025-03-20 | |
| 2022-09-30 | $5.94M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $8.83M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $11.93M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $14.60M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $6.13M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $9.48M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $13.15M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $7.20M 10-K · filed 2023-03-30 | |
| 2020-09-30 | $9.51M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $12.34M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $7.74M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $12.29M 10-K · filed 2022-03-31 | |
| 2019-09-30 | -$21.08M 10-Q · filed 2020-11-13 | -$1.02M 10-Q · filed 2019-11-08 |
| 2019-06-30 | -$17.50M 10-Q · filed 2020-11-13 | $1.96M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$15.69M 10-Q · filed 2020-11-13 | $4.45M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$13.29M 10-K · filed 2021-04-15 | $7.77M 10-K · filed 2019-03-18 |
| 2018-09-30 | $10.85M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $15.05M 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $20.82M 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $25.00K 10-K · filed 2020-03-30 | $3.94M 10-K · filed 2018-03-20 |
| 2017-09-30 | $9.95M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $17.73M 10-Q · filed 2018-11-08 | |
| 2017-03-31 | $25.30M 10-Q · filed 2018-11-08 | |
| 2016-12-31 | $20.63M 10-K · filed 2019-03-18 | |
| 2016-09-30 | $26.99M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | -$15.96M 10-Q · filed 2017-08-14 | |
| 2016-03-31 | -$14.51M 10-Q · filed 2017-05-10 | |
| 2015-12-31 | -$12.38M 10-K · filed 2019-03-18 | |
| 2015-09-30 | -$8.72M 10-Q · filed 2016-11-02 | |
| 2015-06-30 | -$6.09M 10-Q · filed 2016-09-14 | |
| 2014-12-31 | -$531.00K 10-K · filed 2018-03-20 | |
| 2013-12-31 | -$264.00K 10-K · filed 2017-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |